Description: Larifer-XT Injection is an intravenous (IV) iron supplement containing iron sucrose, designed to rapidly elevate and restore hemoglobin levels in patients with severe iron deficiency anemia, including pregnant women.
Key Benefits:
- Rapid hemoglobin elevation
- Safety and effectiveness
- Prevention of anemia-related complications
Indications:
- Severe iron deficiency anemia
- Anemia during pregnancy
- Nephrology:
– Chronic kidney disease (CKD) patients on dialysis
– Iron deficiency anemia in patients with kidney transplant
- Gastroenterology:
– Inflammatory bowel disease (IBD) patients with iron deficiency anemia
– Gastrectomy or gastric bypass patients with iron deficiency
- Oncology: Cancer patients with chemotherapy-induced anemia
Precautions:
- Hypersensitivity to iron sucrose or other ingredients
- Iron overload or hemochromatosis
- Cardiac history (heart failure, myocardial infarction)
- Infections (monitor for signs of infection)
- Renal impairment (dosage adjustment may be necessary)
- Pregnancy and breastfeeding (discuss risks and benefits with healthcare provider)
- Drug interactions (inform doctor about all medications)
Dosage and Administration:
- Administer IV injection over 5-10 minutes
- Dose: 100-200 mg elemental iron per dose
- Frequency: As prescribed by healthcare provider
Contraindications:
- Hypersensitivity to iron sucrose or other ingredients
- Iron overload or hemochromatosis
Nephrology Considerations:
- Monitor iron levels and adjust dosage accordingly
- Use with caution in patients with kidney transplant
- Avoid using Larifer-XT Injection in patients with severe kidney impairment
Gastroenterology Considerations:
- Monitor for gastrointestinal side effects
- Use with caution in patients with inflammatory bowel disease (IBD)
Oncology Considerations:
- Monitor for chemotherapy-induced anemia
- Use Larifer-XT Injection in combination with chemotherapy
Storage and Handling:
- Store at room temperature (20-25°C)
- Protect from light and moisture
- Use within expiration date
Packaging:
- Vials of 100 mg/5 mL elemental iron
- Cartons of 10 vials
Label Claims:
- Rapidly elevates hemoglobin levels
- Safe and effective treatment for iron deficiency anemia
- Prevents anemia-related complications
Regulatory Compliance:
- Compliant with GMP and DCGI guidelines.
- Meets IP standards.
References:
- “Iron deficiency anemia during pregnancy” (American College of Obstetricians and Gynecologists, 2020)
- “Intravenous iron supplementation in CKD patients” (National Kidney Foundation, 2020)
- “Iron deficiency anemia in cancer patients” (American Society of Clinical Oncology, 2020)